Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis

Pediatric Ulcerative Colitis Clinical Trial

Official title:
Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of TA-650 in Pediatric Patients With Moderate to Severe Ulcerative Colitis.

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the the efficacy of TA-650 using Clinical activity index (CAI) score and other evaluation indicators in pediatric patients with moderate to severe ulcerative colitis after TA-650 administration of at a dose of 5 mg/kg at weeks 0, 2, and 6, and then every 8 weeks at weeks 14 and 22. The safety and pharmacokinetics are also evaluated.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01585155
Study type	Interventional
Source	Mitsubishi Tanabe Pharma Corporation
Contact
Status	Completed
Phase	Phase 3
Start date	February 2012
Completion date	September 2014

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT04348890` - Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis	Phase 1/Phase 2
Recruiting	`NCT05673278` - Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study
Completed	`NCT05591976` - Exercise Training in Youth With Inflammatory Bowel Disease	N/A
Terminated	`NCT03827109` - Peer Mentoring to Improve Self-management in Youth With IBD	N/A
Terminated	`NCT02694042` - Mission is Remission®: How Can a Disease Self-management Website Change Care?	N/A